Asian Markets Rally as Oil Prices Tumble and Middle East Peace Hopes Emerge 
AWS Bahrain Region Disrupted by Drone Activity Amid Middle East Conflict 
NAB Plans to Cut 170 Jobs While Expanding Offshore Operations 
France's 2025 Budget Deficit Shrinks More Than Expected, Easing Fiscal Pressure 
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore 
Air Canada Express Crash at LaGuardia: Controller Distracted by Prior Emergency 
OpenAI Pulls the Plug on Sora, Ending $1 Billion Disney Partnership 
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions 
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis 
U.S. Stocks Tumble as Iran Peace Deal Uncertainty Spooks Markets 
Nanya Technology Shares Surge 10% After $2.5 Billion Private Placement from Sandisk and Cisco 
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 
Bank of Japan Unveils New Inflation Gauge to Support Case for Future Rate Hikes 
Dollar Strengthens as U.S.-Iran Peace Talks Send Mixed Signals 
Namyang Dairy saw a surge in its shares after claiming its Bulgaris yogurt variants can help lower the risk of COVID-19 infection. The company's day trading on Wednesday, April 14, reportedly increased.
As per The Korea Herald, Namyang Dairy’s shares once shot up by 28.68% to KRW489,000 or around $437.39 in the early morning trading. It was added that within 20 minutes after the opening bell, the company’s preferred stocks also surge by the daily allowable limit of 29.78% to reach KRW231,000.
Prior to Wednesday’s results, it was reported that the firm’s shares went up 7.19% and 6.71% on Friday and Monday, respectively. It then increased again by 8.57% on Tuesday, and this shows that Namyang Dairy’s shares have been on the rise since last weekend and continued this week.
Namyang’s COVID-19 claim
Observers are saying that the company’s surge in shares may be due to its claims that its Bulgaris yogurt lineup can help reduce the risk of getting COVID-19. Some market insiders also think that some investors may have also used information that caused the hike in the recent stock tradings.
At any rate, what triggered the sudden increase in shares of Namyang Dairy was the statement given by the company during a news conference in Seoul.
“We’re the first firm in the country that has discovered fermented dairy products are effective in preventing influenza and COVID-19 viruses,” Namyang’s chief of antiviral immune research center, Park Jong Su, said at that time. “Our experiments showed that Bulgaris helped remove the Influenza A (H1N1) virus at a 99.999 percent rate of success, and the COVID-19 at a 77.8 percent success rate.”
He added that the test of the yogurt’s effectiveness in fighting coronavirus was done using the lung cells of a monkey. As a result of this claim, people reportedly rushed out to purchase Namyang Dairy’s Bulgaris yogurts in stores.
Statement from S. Korea’s health officials
After the announcement from Namyang, the public health authorities released a statement. The agency expressed its concern over the claims.
“The latest research result has not proved to be effective in eliminating those viruses in the human body,” the Korea Disease Control and Prevention Agency stated. “Therefore, it is hard to say whether it can serve as an actual prevention or treatment measure for (the viruses).”
